EPCAM and neoplasm: In the EpCAM/OVCAR-5 model, FLRT3 expression on tumors significantly reduced T cell–mediated antitumor immunity, inhibited T cell TME recruitment/infiltration, and reduced T cell engagement (close interaction) with tumor cells (Fig. 5C).